Cite

MLA Citation

    JY Humrich et al.. “A7.06 Low-dose IL-2 therapy in refractory sle: Insights from a phase I/IIA clinical trial.” Annals of the rheumatic diseases, vol. 75, n.d., p. A58. http://access.bl.uk/ark:/81055/vdc_100137792709.0x000060
  
Back to record